Akeso agrees clinical trial collaboration with INOVIO

Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation

Frontage Laboratories acquires Teddy Clinical Research Laboratory in China

Allergy Therapeutics reports positive biomarker data from PROTECT trial

HUTCHMED doses first patient in global trial of ATTC candidate HMPL-A580

Ensorcell adds new senior leadership team members

Sino Biological launches 2026-2027 Northern Hemisphere influenza vaccine strain antigens

Sanaregen receives FDA clearance for retinal degeneration clinical trial

Lynk Pharmaceuticals reveals positive topline results from zemprocitinib Phase III clinical trial

ReviR Therapeutics doses first participant in First-in-Human Phase 1 clinical trial of RTX-117

Ono Pharmaceutical expands multi-target research collaboration with Congruence Therapeutics

United Therapeutics' ralinepag reduces risk of clinical worsening in pivotal PAH study

Genentech's fenebrutinib meets primary endpoint in pivotal Phase III study for multiple sclerosis

ValiRx establishes animal health subsidiary to target veterinary oncology market

FDA accepts rusfertide NDA and grants priority review for polycythemia vera